• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症与肝癌发生的转化桥梁。

The Translational Bridge between Inflammation and Hepatocarcinogenesis.

机构信息

Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Clinical Institute of Pathology, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, 3100 St. Poelten, Austria.

出版信息

Cells. 2022 Feb 3;11(3):533. doi: 10.3390/cells11030533.

DOI:10.3390/cells11030533
PMID:35159342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8834218/
Abstract

Viral infections or persistent alcohol or drug abuse, together with intrinsic factors, lead to hepatitis, which often ends in the development of liver cirrhosis or hepatocellular carcinoma (HCC). With this review, we describe inflammatory liver diseases, such as acute liver failure, virus-induced hepatitis, alcoholic- and non-alcoholic steatohepatitis, and autoimmune hepatitis, and highlight their driving mechanisms. These include external factors such as alcohol misuse, viral infection and supernutrition, as well as intrinsic parameters such as genetic disposition and failure, in immune tolerance. Additionally, we describe what is known about the translational machinery within all these diseases. Distinct eukaryotic translation initiation factors (eIFs) with specific functional roles and aberrant expression in HCC are reported. Many alterations to the translational machinery are already triggered in the precancerous lesions described in this review, highlighting mTOR pathway proteins and eIFs to emphasize their putative clinical relevance. Here, we identified a lack of knowledge regarding the roles of single eIF proteins. A closer investigation will help to understand and treat HCC as well as the antecedent diseases.

摘要

病毒感染或长期酗酒、吸毒,再加上内在因素,导致肝炎,常发展为肝硬化或肝细胞癌(HCC)。通过本文综述,我们描述了炎症性肝病,如急性肝衰竭、病毒引起的肝炎、酒精性和非酒精性脂肪性肝炎以及自身免疫性肝炎,并强调了它们的驱动机制。这些机制包括酒精滥用、病毒感染和营养过剩等外在因素,以及免疫耐受中的遗传易感性和衰竭等内在因素。此外,我们还描述了所有这些疾病中转录机制的相关知识。已有报道称,在 HCC 中存在具有特定功能作用和异常表达的不同真核起始因子(eIF)。在本文综述中描述的癌前病变中,已经触发了许多对翻译机制的改变,突出了 mTOR 通路蛋白和 eIF 的作用,以强调它们的潜在临床相关性。在这里,我们发现了对单个 eIF 蛋白作用的认识不足。更深入的研究将有助于理解和治疗 HCC 以及其前身疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/8dd01ba679c8/cells-11-00533-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/a6bbe4eba0a7/cells-11-00533-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/6904d277bb8d/cells-11-00533-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/c1cef62d4ec5/cells-11-00533-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/29fb6d147b12/cells-11-00533-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/8dd01ba679c8/cells-11-00533-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/a6bbe4eba0a7/cells-11-00533-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/6904d277bb8d/cells-11-00533-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/c1cef62d4ec5/cells-11-00533-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/29fb6d147b12/cells-11-00533-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dbe/8834218/8dd01ba679c8/cells-11-00533-g005.jpg

相似文献

1
The Translational Bridge between Inflammation and Hepatocarcinogenesis.炎症与肝癌发生的转化桥梁。
Cells. 2022 Feb 3;11(3):533. doi: 10.3390/cells11030533.
2
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.新型肝癌生物标志物:PI3K/AKT/mTOR信号通路成员与真核生物翻译起始因子
Eur J Cancer. 2017 Sep;83:56-70. doi: 10.1016/j.ejca.2017.06.003. Epub 2017 Jul 14.
3
Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma.分子发病机制:病毒性肝炎引起的和非酒精性脂肪性肝炎引起的肝细胞癌之间的联系。
Front Immunol. 2022 Sep 15;13:984728. doi: 10.3389/fimmu.2022.984728. eCollection 2022.
4
Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?酒精的代谢衍生物与纤维性肝癌发生的分子元凶:盟友还是敌人?
World J Gastroenterol. 2016 Jan 7;22(1):50-71. doi: 10.3748/wjg.v22.i1.50.
5
Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.酒精、微生物群、生活方式会影响酒精性和非酒精性器官损伤。
Exp Mol Pathol. 2017 Feb;102(1):162-180. doi: 10.1016/j.yexmp.2017.01.003. Epub 2017 Jan 7.
6
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.非酒精性脂肪性肝病相关肝细胞癌:日益受到关注。
Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17.
7
Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis.非酒精性脂肪性肝炎相关多阶段肝癌发生过程中的全基因组DNA甲基化分析:与肝炎病毒相关致癌作用的比较
Carcinogenesis. 2017 Mar 1;38(3):261-270. doi: 10.1093/carcin/bgx005.
8
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
9
[Alcoholic liver diseases in Japan and modification by hepatitis virus].[日本的酒精性肝病及肝炎病毒的影响]
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2003 Oct;38(5):403-14.
10
The metabolomic window into hepatobiliary disease.代谢组学在肝胆疾病中的应用。
J Hepatol. 2013 Oct;59(4):842-58. doi: 10.1016/j.jhep.2013.05.030. Epub 2013 May 25.

引用本文的文献

1
Eukaryotic initiation factors: central factor associating mRNA translational plasticity during neuropathic pain progression.真核生物起始因子:在神经性疼痛进展过程中与mRNA翻译可塑性相关的核心因子。
Front Neurol. 2025 Jul 30;16:1566205. doi: 10.3389/fneur.2025.1566205. eCollection 2025.
2
Advances in Organic Small Molecule-Based Fluorescent Probes for Precision Detection of Liver Diseases: A Perspective on Emerging Trends and Challenges.基于有机小分子的荧光探针用于肝脏疾病精准检测的研究进展:新兴趋势与挑战展望
J Am Chem Soc. 2025 Mar 19;147(11):9001-9018. doi: 10.1021/jacs.4c17092. Epub 2025 Mar 4.
3
Carnitine palmitoyltransferase-II inactivity promotes malignant progression of metabolic dysfunction-associated fatty liver disease liver cancer stem cell activation.

本文引用的文献

1
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma.靶向肝细胞癌中的PI3K/Akt/mTOR信号通路
Biomedicines. 2021 Nov 8;9(11):1639. doi: 10.3390/biomedicines9111639.
2
Translational Regulation in Hepatocellular Carcinogenesis.翻译:肝细胞癌发生中的翻译调控。
Drug Des Devel Ther. 2021 Oct 14;15:4359-4369. doi: 10.2147/DDDT.S255582. eCollection 2021.
3
Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis.病毒状态与免疫疗法在肝细胞癌中的疗效:系统评价与荟萃分析。
肉碱棕榈酰转移酶-II活性缺失促进代谢功能障碍相关脂肪性肝病肝癌干细胞激活的恶性进展。
World J Gastroenterol. 2024 Dec 21;30(47):5055-5069. doi: 10.3748/wjg.v30.i47.5055.
4
Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children's Hospital of Eastern Ontario grossing protocol.代谢相关脂肪性肝病(MAFLD)的肝脏活检处理:安大略东部儿童医院大体标本处理方案
Ther Adv Endocrinol Metab. 2024 Feb 4;15:20420188241227766. doi: 10.1177/20420188241227766. eCollection 2024.
5
Identification of the key genes and mechanisms associated with transcatheter arterial chemoembolisation refractoriness in hepatocellular carcinoma.肝细胞癌经动脉化疗栓塞难治性相关关键基因及机制的鉴定
World J Clin Oncol. 2024 Jan 24;15(1):62-88. doi: 10.5306/wjco.v15.i1.62.
6
Profile and clinical significance of interferon gamma-inducible protein-10 (IP-10) and its receptor in patients with hepatocellular carcinoma.干扰素γ诱导蛋白-10(IP-10)及其受体在肝癌患者中的特征和临床意义。
J Cancer Res Clin Oncol. 2023 Nov;149(16):14879-14888. doi: 10.1007/s00432-023-05265-1. Epub 2023 Aug 20.
7
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy.肝细胞癌的发病机制:细胞凋亡与自噬的相互作用
Biomedicines. 2023 Apr 13;11(4):1166. doi: 10.3390/biomedicines11041166.
8
Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma.翻译:肝细胞癌中代谢和细胞周期进程的翻译调控。
Int J Mol Sci. 2023 Mar 3;24(5):4885. doi: 10.3390/ijms24054885.
9
Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中肝细胞癌的非实质细胞与细胞外基质
Cancers (Basel). 2023 Feb 18;15(4):1308. doi: 10.3390/cancers15041308.
Front Immunol. 2021 Sep 29;12:733530. doi: 10.3389/fimmu.2021.733530. eCollection 2021.
4
Pathology of autoimmune hepatitis.自身免疫性肝炎的病理学。
Pathologica. 2021 Jun;113(3):185-193. doi: 10.32074/1591-951X-241.
5
Structural perspectives on HCV humoral immune evasion mechanisms.HCV 体液免疫逃逸机制的结构观点。
Curr Opin Virol. 2021 Aug;49:92-101. doi: 10.1016/j.coviro.2021.05.002. Epub 2021 Jun 3.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
8
Recent updates on the management of autoimmune hepatitis.自身免疫性肝炎的最新治疗进展。
Clin Mol Hepatol. 2021 Jan;27(1):58-69. doi: 10.3350/cmh.2020.0189. Epub 2020 Dec 10.
9
Interplay between Hepatitis D Virus and the Interferon Response.乙型肝炎病毒与干扰素反应的相互作用。
Viruses. 2020 Nov 20;12(11):1334. doi: 10.3390/v12111334.
10
The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.肠道屏障、肠道微生物群与肝病:管理的分子机制与策略。
Int J Mol Sci. 2020 Nov 7;21(21):8351. doi: 10.3390/ijms21218351.